Dawn E Sugarman
Affiliation: Yale University
- The safety of modafinil in combination with oral ∆9-tetrahydrocannabinol in humansDawn E Sugarman
Yale University School of Medicine, Department of Psychiatry, 300 George St, New Haven, CT 06511, USA
Pharmacol Biochem Behav 98:94-100. 2011..These findings support the safety of modafinil in combination with THC. The effects of modafinil in combination with a range of doses of THC need to be determined in future studies...
- Coping strategy use following computerized cognitive-behavioral therapy for substance use disordersDawn E Sugarman
Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06516, USA
Psychol Addict Behav 24:689-95. 2010....
- Cognitive function as an emerging treatment target for marijuana addictionMehmet Sofuoglu
Department of Psychiatry, Yale University School of Medicine, and VA Connecticut Healthcare System, West Haven, Connecticut 06516, USA
Exp Clin Psychopharmacol 18:109-19. 2010..Future clinical studies optimally designed to measure cognitive function as well as drug use behavior would be needed to test the efficacy of these treatments for marijuana addiction...
- A methodological analysis of randomized clinical trials of computer-assisted therapies for psychiatric disorders: toward improved standards for an emerging fieldBrian D Kiluk
Departmentof Psychiatry, Yale University School of Medicine, West Haven, CT, USA
Am J Psychiatry 168:790-9. 2011..However, the extent to which the growing body of randomized trials evaluating computer-assisted therapies meets current standards of methodological rigor for evidence-based interventions is not clear...